CML Horizons 2017 - Save the date: 26-28 May 2017

thumb save date image

Join us for the 15thCML Horizons: Learn. Share. Grow" Conference
DATE: 26TH TO 28TH MAY 2017
LOCATION: FRANKFURT, GERMANY

download

Equip yourself with knowledge on how to make a difference to the lives of patients, identify opportunities in patient support & advocacy, empower yourself & gain the courage to fight for the rights of CML patients, learn from the experts - both patient advocates and physicians. 

This exciting one of its kind conference will enable you to be able to exchange ideas, interact & share best practice. You will also have the opportunity start networking across borders and build alliances and so much more for you to bring back to your own organization. 
 
Registration process will start the 2nd week of January 2017 and will inform you as soon as the registration platform is online.

Read more ...

ASH 2016 update on stopping CML treatment with TKIs in deep molecular response

American Society of Hematology logo.svg 1 Tyrosine kinase inhibitors (TKI) have dramatically improved survival of CML and made it a chronic disease. However, life-long therapy is still advised according to expert recommendations and the product labels of current TKI treatments. Depending on the choice of TKI, about 40-70% of CML patients reach a deep molecular response, meaning a BCR-ABL ratio of 0.01% (MR4) or below. Given it had been observed that some patients were able to stop treatment in deep remission without a recurrence of the disease, the effectiveness of stopping TKI treatment of CML patients at large having a sustained, deep molecular response is a key question that is being investigated in various studies, and is probably the most debated CML topic at this year’s ASH.

We are summarizing the most important presentations, discussions and posters on that important topic at the ASH congress this year.

Read more ...

Welcome, CML Palestine (Palestine) - now 110 patient organisations from 83 countries in the CML Advocates Network

We are proud to welcome a new member organisation to the CML Advocates Network: CML Palestine based in Palestine. The CML Advocates Network now totals at 110 member organisations in 83 countries worldwide! See the list of CML groups in the Network on our world map.

Today is World CML Day - 9/22

WCMLD 2013 0922logo día mundial LMCLogo Today TogetherTODAY IS WORLD CML DAY!

One day, one community, one life changing reality… Today we unite to take World CML Day global!
Today we are together to take a stand, share our needs and raise awareness!

Screenshot CML Today 1Screenshot CML Today 2Today and all week long in September organizations around the globe are celebrating World CML Day through their activities, by sharing their achievements over the past year and by pointing out the problems they are still facing.

CML ADHERENCE APP “CML Today” is celebrating its 1st birthday! “CML Today” is an app that has been developed to support adherence to TKIs as well as to track patients` PCR results. The mobile app is now available in 7 languages: English, German, French, Spanish, Portuguese, Hebrew and Arabic with more languages to follow. You can download „CML Today“ free-of-charge from the Apple App Store (iphone) and in the Google PlayStore (Android). Please talk about “CML Today” and encourage CML patients to use “CML Today”!

Please also check out the activities that are taking place all over the world on World CML Day 2016 and the campaign materials developed by members of the CML Advocates Network - and do not forget to share your activities with us and other groups! Last but not least, don´t miss our Facebook-page!

More information on World CML Day 2016 can be found here.

The CML Advocates Network wishes everybody an inspiring and successful World CML Day 2016!

wcmld15 key-audiences

 

Tomorrow is World CML Day 2016!

WCMLD 2013 0922Logo Today Together... is the motto for this year´s World CML Day campaign, which will take place tomorrow, Thursday Sept 22!

One day, one community, one life changing reality…

Today, together we can make World CML Day more visible and engaging! Together we can make it global!

In order to help you spread the message of awareness and strengthen your voice, the CML Advocates Network has developed a World CML Day toolkit to make this day global and unique. The toolkit includes adaptable artwork for print and online use (posters & flyers), a photo database and a press release.

Check out our members´ campaign materials and also don´t miss our Facebook-page.

Please share photos and activities of your World CML day with us by e-mailing to nicole@cmladvocates.net, so we can add them to our list of worldwide activities and to our photo gallery.

We wish you all an inspiring and successful World CML Day 2016!

wcmld15 key-audiences

 

The CML Advocates Network's Clinical Trials Registry currently lists 27 CML studies

Set up and driven by CML Advocates Network, the Clinical Trials Registry provides patients with easy access to information on ongoing CML studies. Entries are updated at regular intervals: new studies and sites are added whereas completed or terminated studies are no longer shown on the registry. Currently 27 CML studies from many countries around the world are listed. The most recent additions to the registry are:

  • OPTIC, a study to determine the efficacy and safety of ponatinib in patients with resistant CML in chronic phase. This study is including patients in 19 countries on five continents.
  • ENESTPath Patient’s Voice Italian Substudy. This study is exploring the emotional experience of patients participating in the ENESTPath study with nilotinib. The substudy is available only in Italy.

Eleven studies are ongoing but no longer recruiting new patients. These studies have been moved to the category "Trials that are no longer recruiting".Two trials have been completed or terminated: Spirit 3 and NordDutchCML006. They are no longer ongoing and therefore not any more listed on the database.

We would like to thank everyone for sharing information with us on new studies or changes in ongoing studies. Your invaluable input helps us keep the registry up to date. Thank you.

Do you know of any study that is not yet listed in our Clinical Trial Database? Please let us know by filling out this form. Or is there an entry which should be corrected? If so, please send us an email. Please also visit our discussion forum if you have any questions or wish to share your experience on these studies!

Please donate!

Please donate!

LogIn

EU e-Privacy Directive